21 C.F.R. § 14.30 Chairman of an advisory committee.
Title 21 - Food and Drugs
(a) The advisory committee chairman has the authority to conduct hearings and meetings, including the authority to adjourn a hearing or meeting if the chairman determines that adjournment is in the public interest, to discontinue discussion of a matter, to conclude the open portion of a meeting, or to take any other action to further a fair and expeditious hearing or meeting. (b) If the chairman is not a full-time employee of FDA, the executive secretary or other designated agency employee, or alternate, is to be the designated Federal employee who is assigned to the advisory committee. The designated Federal employee is also authorized to adjourn a hearing or meeting if the employee determines adjournment to be in the public interest.
Title 21: Food and Drugs
PART 14—PUBLIC HEARING BEFORE A PUBLIC ADVISORY COMMITTEE
Subpart B—Meeting Procedures
§ 14.30 Chairman of an advisory committee.
